The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Kactus Biosystems
-
11-50 Employees
2018
Key takeaway
KACTUS is a biotech company that specializes in high-purity recombinant proteins and enzymes, including TelN Protelomerase (TLN-BE001), which may be relevant for applications in telomerase research. Their proprietary SAMSâ„¢ platform and commitment to quality support advancements in fields like antibody drug discovery and mRNA therapeutics.
Reference
Product
TelN Protelomerase (TLN-BE001) – KACTUS
Telomium
Ivry-sur-Seine, France
A
1-10 Employees
2016
Key takeaway
Telomium is a biotechnology company focused on developing immunotherapies, with a notable product, TLVX01, that specifically targets telomerase, which is found in 90% of cancers. Their technology has demonstrated strong preclinical activity in dogs with large spontaneous tumors, highlighting its potential in oncology.
Reference
Core business
Telomium – Immunotherapy
Repeat Diagnostics Inc (RepeatDx)
North Vancouver, Canada
A
1-10 Employees
2005
Key takeaway
RepeatDx is a specialized clinical laboratory that offers Telomere Length Analysis across all 50 US States and Territories, making it a key player in this field. Their testing services provide valuable clinical insights for various conditions, including myelodysplastic syndromes and acute myeloid leukemia.
Reference
Core business
Telomere testing for healthcare professionals | RepeatDx
Learn about telomeres and our telomere testing services. RepeatDx is the leading clinical laboratory in telomere aging analysis.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Epiterna
Épalinges, Switzerland
A
1-10 Employees
-
Key takeaway
EPITERNA focuses on translating scientific discoveries into products that can safely slow the aging process and extend life, addressing key health issues related to aging. Their mission is to improve the quality of life for both pets and people by preventing age-related diseases and functional decline.
Reference
Core business
EPITERNA About
Healthycell
Charleston, United States
B
1-10 Employees
2018
Key takeaway
Healthycell offers a product that supports the length of telomeres by providing bioactive phytonutrients that help maintain telomerase levels. This focus on telomere health is part of their commitment to proactive health management through advanced nutrient delivery technology.
Reference
Product
Telomere Length (7-serv) – Healthycell
Support the length of your telomeres with bioactive phytonutrients that help maintain telomerase levels, repair cellular DNA, boost nitric oxide, and inhibit homocysteine.â€
Genebio
-
- Employees
-
Key takeaway
GeneBio Systems offers a partial Recombinant Human Telomerase protein component 1 (TEP1), highlighting their commitment to providing high-performance products for the scientific community, particularly in Molecular and Cellular Biology research.
Reference
Product
Recombinant Human Telomerase protein component 1(TEP1),partial – GeneBio Systems
Recombinant Human Telomerase protein component 1(TEP1),partial
TelCyte Infrastructure
Dartmouth, Canada
A
11-50 Employees
2017
Key takeaway
TelCyte is a comprehensive telecom and infrastructure solutions provider, emphasizing the importance of structured processes for business success.
Reference
Core business
HOME | Telcyte
Geron
Menlo Park, United States
B
11-50 Employees
1990
Key takeaway
Geron is focused on advancing telomerase inhibition as a promising treatment for blood cancers, highlighting its potential to extend and enhance patients' lives. With significant clinical development experience, Geron is well-positioned to develop and commercialize its first-in-class investigational telomerase inhibitor.
Reference
Core business
Our tireless pursuit | Geron
We’re committed to bringing the potential power of telomerase inhibition to patients.
Neuromagen Pharma
Israel
B
- Employees
2021
Key takeaway
Neuromagen Pharma is focused on developing innovative small molecules that activate Telomerase Reverse Transcriptase (TERT), an enzyme crucial for preventing cellular senescence. Their research aims to delay the progression of neurodegenerative diseases, particularly ALS, by enhancing cell lifespan and survival through TERT activation.
Reference
Core business
Neuromagen Pharma Ltd.
Our goal is to develop drugs which will delay the onset, and the progression of neurodegenerative diseases and specifically of ALS and improve and extend patients’ lives
MAIA Biotechnology
Chicago, United States
B
1-10 Employees
2018
Key takeaway
MAIA Biotechnology, Inc. is developing innovative cancer therapies, with a focus on telomere targeting through their lead asset, THIO. This investigational drug candidate incorporates a dual mechanism of action that aims to enhance immunogenicity and extend the lives of cancer patients.
Reference
Core business
Home - Maia Biotechnology
Technologies which have been searched by others and may be interesting for you:
Telomerase is an enzyme that plays a crucial role in maintaining the length of telomeres, which are protective caps located at the ends of chromosomes. These telomeres shorten with each cell division, leading to cellular aging and eventual cell death. By adding repetitive nucleotide sequences to the ends of telomeres, telomerase helps to counteract this shortening process, allowing cells to divide more times than they otherwise would. This activity is particularly significant in stem cells, germ cells, and certain cancer cells, where prolonged cell division is necessary for growth and regeneration. Understanding telomerase has implications in aging research and cancer therapies, making it a vital area of study in biotechnology and molecular biology.
Telomerase is an enzyme that plays a crucial role in cellular aging and replication. It functions by adding repetitive nucleotide sequences to the ends of chromosomes, known as telomeres. These telomeres protect the chromosome from degradation and prevent the loss of essential genetic information during cell division. In normal somatic cells, telomerase activity is low or absent, leading to telomere shortening with each cell division. This shortening is associated with aging and limits the number of times a cell can divide. However, in stem cells and certain cancer cells, telomerase is highly active, allowing for indefinite cell division and contributing to tissue regeneration and tumor growth. By maintaining telomere length, telomerase helps ensure cellular longevity and stability.
Telomerase is an enzyme that plays a crucial role in maintaining the length of telomeres, the protective caps at the ends of chromosomes. As cells divide, telomeres shorten, which eventually leads to cell aging and death. In many somatic cells, telomerase activity is low or absent, contributing to the aging process. In contrast, stem cells and certain immune cells express telomerase, which helps preserve their telomere length and extend their lifespan. Research suggests that reactivating telomerase may have implications for slowing down aging and enhancing cellular longevity. However, uncontrolled telomerase activity can lead to cancer, making its regulation a critical area of study in both aging and oncology.
Telomerase plays a crucial role in cellular aging and has been extensively studied in the context of cancer. This enzyme extends the telomeres, which are protective caps at the ends of chromosomes. In normal somatic cells, telomerase activity is low or absent, leading to telomere shortening and eventual cell senescence. However, many cancer cells exhibit high levels of telomerase, allowing them to maintain telomere length, evade apoptosis, and proliferate indefinitely. The activation of telomerase is often associated with tumorigenesis and is considered a hallmark of cancer cells. Thus, while telomerase itself is not a direct cause of cancer, its upregulation is frequently linked to cancer development and progression.
Potential therapies involving telomerase focus on its role in cellular aging and cancer treatment. Researchers are investigating telomerase activation as a means to extend the lifespan of healthy cells, which could lead to advancements in regenerative medicine. This approach aims to enhance tissue repair and combat age-related diseases. On the other hand, telomerase inhibition is being explored in oncology, as many cancer cells express telomerase to maintain their immortality. By targeting telomerase, therapies could effectively limit tumor growth and promote cancer cell death. The dual aspects of telomerase in both promoting longevity in healthy cells and suppressing cancer cell proliferation highlight its significance in potential therapeutic approaches.
Some interesting numbers and facts about your company results for Telomerase
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 4564 |
| Amount of suitable service providers | 3353 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1990 |
| Youngest suiting company | 2021 |
20%
40%
60%
80%
Some interesting questions that has been asked about the results you have just received for Telomerase
What are related technologies to Telomerase?
Based on our calculations related technologies to Telomerase are Aromatics, Desiccants, Refrigerants, Resins, Green Chemistry
Which industries are mostly working on Telomerase?
The most represented industries which are working in Telomerase are Biotechnology, Other, IT, Software and Services, Healthcare, Telecommunications
How does ensun find these Telomerase Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
